Tesnatilimab (Anti-NKG2D / CD314)
Tesnatilimab (Anti-NKG2D / CD314) is a recombinant human immunoglobulin G4 (IgG4) monoclonal antibody against the immune activating receptor natural-killer group 2, member D receptor protein (NKG2D or KLRK1), with potential immunomodulating and anti-inflammatory activities. MW: 146.5 kD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2390 |
Sku # | A2390-1mg*5 |
Pricing | 1mg*5, $1390.00 |